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Abstract: This paper proposes an integrated modelling approach for location planning of
radiotherapy treatment services based on cancer incidence and road network-based
accessibility. Previous research efforts have established travel distance/time barriers as a key
factor affecting access to cancer treatment services, as well as epidemiological studies have
shown that cancer incidence rates vary with population demography. Our study is buil on the
evidence that the travel distances to treatment centres and demographic profiles of the
accessible regions greatly influence the uptake of cancer radiotherapy (RT) services. An
integrated service planning approach that combines spatially-explicit cancer incidence
projections, and the placement of new RT services based on road network based accessibility
measures have never been attempted. This research presents a novel approach for the location
planning of RT services, and demonstrates its viability by modelling cancer incidence rates
for different age-sex groups in New South Wales, Australia based on observed cancer
incidence trends; and estimations of the road network-based access to current NSW treatment
centres. Using three indices (General Efficiency, Service Availability and Equity), we show
how the best location for a new RT centre may be chosen when there are multiple competing
locations.
Keywords: radiotherapy services, cancer, location planning, accessibility

1. Introduction
Cancer control is a health priority. Cancer is estimated to be the leading cause of burden of
disease in Australia in 2010, accounting for 19% of the total burden, and has a major impact
on the Australian community, since one in three men and one in four women in Australia will
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be diagnosed with cancer by the age of 75. By age 85, the risk increases to one in two for
men and one in three for women (Cancer Council Australia, 2012). The proportion of elderly
people in the population will steadily increase over the next decades due to increased life
expectancy (ROTC, 2012a) and the ‘baby boomers’ ageing population is entering the high
incidence period, thereby increasing the number of cancer cases.
Beyond demographic influences, other factors like socio-economic status and ethnicity have
also an effect on cancer incidence (ROTC, 2012a) along with geographical variations in the
rate of treatment and survival from cancer (Coory et al., 2013; Yu et al., 2014). As the
number and diversity of cancer cases increase, the pressure on specialised treatment services
will increase, calling for better planning and allocation of healthcare resources, particularly at
the regional level.
Radiotherapy (RT) is an essential cancer therapy whether aimed at cure or palliation. The
Collaboration for Cancer Outcomes Research and Evaluation (CCORE) literature-based
findings were used by the Radiation Oncology Reform Implementation Committee (RORIC)
to estimate that 52.3% of all diagnosed cancer cases in Australia would benefit from
radiotherapy at some point after diagnosis. The Australian state health department uses this
estimate for planning their RT services (Delaney et al., 2003; ROTC 2012b; Morgan 1999).
Radiotherapy is considered to be most cost effective than surgery and chemotherapy, when
all costs across the life cycle is considered (Ploquin and Dunscombe 2008). According to the
RANZCR, radiotherapy provides similar benefit with lower costs for cancer patient treatment
for cures. RT generally costs about 6 per cent of each health dollar spent fighting cancer, but
it is a vital part of curing about 40 per cent of all cured cancers. As radiation therapy is
provided as an outpatient treatment service, the overall treatment costs are less than other
treatments. In terms of effectiveness, an Australian study stated that external-beam radiation
therapy is at least as effective as modern Australian surgical techniques (Wilcox et al. 2015).
It states that men with localised prostate cancer (≈30.0% of all new cancers in men) who are
treated with external-beam radiation therapy have a cure rate of 95.5% for intermediate-risk
prostate cancer and 91.3% for high-risk prostate cancer. Also, for breast cancer (≈28% of all
new cancers in women) treatment studies conducted in Canada and Denmark, have shown a
9%–10% improvement in overall survival at 10 years for patients that received radiotherapy
compared with patients who did not receive radiotherapy (Vinh-Hung and Verschraegen
2004, Ragaz et al. 1997). Like these there are other studies which show better outcomes and
cost-effectiveness for RT treatments for different types of cancer and their stages.
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However, measured access to RT services has established that utilization rates are well below
this optimal number (Mackillop et al., 1997; Barton 2000; Einhorn et al. 1996; Athas et al.,
2000) clearly demonstrating the existence of barriers to access existing RT services.
Currently, only 38% of cancer sufferers receive radiotherapy during their disease journey
(ROTC 2012a, Barton and Delaney 2011; Denham 1995) indicating that ~14% of cancer
sufferers, miss the benefit from RT services that may improved cancer control and
appropriate evidence-based management (ROTC 2012a, Barton and Delaney 2011). Since the
proximity of RT facilities to home has been identified as a major factor enhancing
accessibility to and utilization of RT services (Mackillop et al., 1997; Denham, 1995), it is
likely that remote and rural patients are facing limited accessibility to radiotherapy on the
basis of inadequate transportation and lengthy travel. A literature review has highlighted
travel as a perceived barrier to cancer treatment (Payne et al., 2000). Several national and
international studies supported the relation between travel distance from radiotherapy centres
and uptake rates (The Allen Consulting Group, 2012; Delaney et al., 2005; Williams 2009;
Cancer Care Ontario, 2008; Schroen et al. 2005; Craft et al., 2010; Badde et al., 2011; Wigg
and Morgan, 2001; Morgan et al., 2010). Although the configuration of centralised networks
may be driven by resource efficiency savings, it has reflecting clinical need in rural and
remote areas will appear less resource efficient (Asthana et al 2003).
Various studies have examined the effect of geographical accessibility, based on travel
times/distances as proxy to travel effort, on uptake of RT based cancer treatment. For
example, Madelaine et al. (2002) reported lower treatment rates for rural lung cancer patients
in France. Punglia et al. (2006) found that increasing distance to the nearest radiotherapy
centre was associated with a decreasing likelihood of receiving post-mastectomy radiation
therapy. Greenberg et al., (1988) asserted that lung cancer patients living at greater straight
line distance from a specialist cancer centre, in rural USA, were significantly more likely to
undergo surgery but were less likely to receive radiotherapy or chemotherapy than closer
patients. Athas et al. (2000) also found that breast cancer patients living further than 75 miles
from a radiotherapy services centre were significantly less likely to receive radiotherapy than
those living closer. It is possible that the detriment of transportation may be even more
pronounced in patients who are faced with weeks of daily outpatient treatment, as is common
for radiation therapy. Some recent studies have reported the location assessment for public
healthcare facilities in US. Batta et al. (2014) has used p-maxian model considering
dispersion, population, and equity for obtaining the optimal locations of public facilities.
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Another study by Burkey et al. (2012) has used location-based comparisons based on
efficiency and equity to compare healthcare services in four US states. Our paper will use
some of these indices (general efficiency, service availability and distance-based equity) to
evaluate the potential RT service locations.
Recently, Gabriel et al. (2012) presented the results from the data linkage study for
radiotherapy utilisation rates in NSW and Australian Capital Territory (ACT) for years 200406. They concluded that the radiotherapy utilisation rates decreased with increasing distance
from patient’s residence to the nearest RT facility (p<0.0001). The study quantified RT rates
ranging from 27% for patient living within 50 km of RT facility to 19% for patients living
more than 400 km from the nearest RT facility. Recently, various studies (Shukla et al
(2014); Shukla et al. (2014); Tyagi et al. (2015)) have only focussed on within organisation
(or hospital) level process improvements but have not considered patient accessibility
measures for improvements.
The planning of efficient and accessible RT services for cancer care at regional level requires
estimates of current and future cancer demand based on the spatial distribution and evolution
of various socio-demographic groups, spatial accessibility based on transport network and
probabilities of re-treatment. In this study, we will develop a modelling tool which can be
systematically used for planning of radiotherapy services.
After detailing the data and methods used in the modelling effort, we will demonstrate how
we have applied these modelling methods to plan and evaluate RT services in NSW.
2. Approach for planning of radiotherapy services
The proposed approach for modelling and predicting the future cancer incidences and their
accessibility to existing RT centres in the state is visualised in Figure 1, and involves datasets
such as Australian Institute of Health and Welfare (AIHW) cancer incidence data, Australian
Bureau of Statistics (ABS) population projection dataset, 1km Australian population grid
dataset, road network dataset, and data about the existing radiotherapy (RT) centres.
2.1 Datasets used in the proposed approach
A. AIHW cancer incidence dataset
The AIHW cancer incidence dataset (AIHW, 2014) provides the information about age group
and sex specific cancer rates for all and specific cancer types in Australia. The major source
4

of this data comes from the Australian Cancer Database (ACD) which contains records of all
the primary, malignant cancers (except basal cell and squamous cell carcinomas of the skin)
diagnosed in Australia since 1982. The data from ACD is generally used to report national
cancer statistics such as incidence, trends, projections, survival, and prevalence. The ACD
data is compiled from the data provided by the state and territory cancer registries through
Australasian Association of Cancer Registries (AACR). The age-specific rates (ASR) for
cancer in males and females, in past years, are used to model and predict the cancer
incidences in the state.
B. ABS population projection dataset
The population projection data prepared by the ABS to permit the Australian Government
Department of Social Services to plan and evaluate aged care. These projections are based on
the past trends (over a decade) of fertility, mortality, and migration trends, using the cohortcomponent method, where the base population is projected into the future year annually by
estimating the effect of births, deaths and migration within each age-sex group according to
the specified fertility, mortality and migration assumptions. This datasets contains the age
group by sex population numbers for each Statistical Local Area. SLA is an Australian
Standard Geographical Classification (ASGC) defined area that covers a Local Government
Area (LGA) or part thereof. The median population of SLAs is about 21,000. The population
projections cover the period from 2012 to 2026, using the 2011 ABS census year as a base.
More information about this dataset is present elsewhere (DoH 2013).
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Figure 1: Methodological approach to determine the accessibility of cancer patients to
radiotherapy centres
C. Australian Population Grid dataset from ABS Australian Bureau of Statistics (ABS) has
released a 1km population grid covering the entire country based on the Census data collected
in 2011. This dataset represents the finest resolution digital population data available at the
national scale According to ABS, this dataset has key advantages of (a) greater spatial
accuracy in both urban and rural areas, and (b) the ability to efficiently integrate with other
spatial datasets such environmental data. This dataset is used in travel distance modelling to
calculate the population coverage.
D. Road network dataset
The road network dataset was downloaded from the most up-to-date OpenStreetMap (OSM)
database, using Quantum GIS software (Gray, 2008). OpenStreetMap is a crowd-sourced
initiative to collect and map roads, trails, and points of interest, with an ultimate aim of
building a geographic database that contains every single feature on the planet (Bennett,
2010). OSM data was selected for this study as it is a readily available and open data source
with sufficient positional accuracy (Haklay, 2010).
E. Existing radiotherapy (RT) centres
The data about the existing RT treatment facilities is accessed from Department of Health,
Australia. DoH (2014) provides publically available information about radiation therapy
services including accommodation and travel schemes, facility locations and treatment
options. The facility locations for RT centres were used for estimating the RT treatment
accessible regions for future cancer incidences.
2.2 Methods
A. Age specific rate (ASR) for cancer incidence modelling
A non-linear polynomial regression model (of degree 3) was used to model the past trend of
the cancer incidences. The polynomial regression models have been developed for each agesex group for male and female. Age specific rates (ASR) from AIHW dataset, for cancer
incidences for years 1982 to 2009, have been used to estimate the coefficients of the
regression model. The model used for ASR regression is:
𝐴𝐴𝑅𝑡 = 𝛽0 + 𝛽1 × 𝑡 + 𝛽2 × 𝑡 2 + +𝛽3 × 𝑡 3 + 𝜀𝑡
6

(1)

Where, 𝐴𝐴𝑅𝑡 is the age-specific rate for a particular age-sex group observed in year 𝑡. 𝜀𝑡 is

assumed to be independent and identically distributed normal random variable with mean
zero and a constant variance.
The AIHW cancer incidence dataset for years 1982-2009 is used for estimating coefficients

𝛽0 - 𝛽3 . The confidence level is set to be 95% for the two sided hypothesis test. If the ASR

model for an age-sex model is found significant, then 𝐴𝐴𝑅𝑡 is estimated based on Eq. (1).

Otherwise, mean of 𝐴𝑆𝑅𝑡 (where, 𝑡 = 2000,2001, … ,2009) for recent 10 years for a particular
age-sex group is used for prediction. In this modelling, we have made following assumptions:
i.

this modelling assumes that the incidence is homogeneous across different local
government areas (LGAs)

ii.

ages were grouped in 5 year interval for this modelling and it assumes that each
age group is homogeneous

iii.

it is assumed that the past trends in cancer incidences will continue in future

B. Predicting the cancer cases
Once the regression models for the cancer incidence is obtained for each age-sex group, it is
then used together with the ABS population projections dataset to estimate the future cancer
cases in the study area. The ABS population dataset is aggregated into a contingency table
having attributes such as age group, sex, geographical area, and number of people at risk.
This data table is then used together with the predicted ASR for each year (derived from
section 2.2.A) to produce cancer cases in different age-sex group in different LGAs. The
result of this analysis provides cancer cases distributed in various LGAs in future. Once the
number of cancer cases for future years are identified, it can be used to estimate the future
radiotherapy demand/workload.
C. Travel distance modelling and the estimation of population coverage
Following the literature that supports a strong relationship between travel distance and uptake
rates (as discussed in Section 1) we calculated driving distance polygons for all treatment
centres using the popular open source software ‘pgRouting’ (pgRouting Contributors, 2013).
Routing functions provided by pgRouting are implemented as an extension to the open source
PostgreSQL/PostGIS geospatial database (Douglas and Douglas, 2005). We were mainly
7

interested in the function ‘pgr_drivingDistance’ to calculate driving distance polygons
(pgRouting Contributors, 2013). This function computes the cost (distance) to reach every
node in the network from a given starting node based on a Dijkstra shortest path solution.
Further details of the Dijkstra algorithm and its applications to road networks can be found in
Zhan and Noon (1998).
Firstly, the OSM road network of NSW was imported into PostgreSQL/PostGIS as a
pgRouting-enabled (i.e. routable) network dataset. A custom SQL function that leverages the
default pgRouting function ‘pgr_drivingDistance’ was written to loop through all treatment
centres. This custom function takes each treatment centre as the starting node, and computes
all nodes in the road network that can be reached within a specified threshold distance. The
concave polygon that encompasses the collection of nodes computed above was then
generated using a standard function available in PostGIS. This concave polygon is termed the
‘constant driving distance polygon’ or isochrone.
Considering the fact that dwellings are not uniformly distributed in space, the digital dataset
of the population grid was used to estimate the fraction of the population that lives in a
particular LGA within a given distance ring.
𝑝
Let 𝑃𝑖,𝑗
be the portion of population of the ith LGA that lives within the jth distance ring, and

𝑃𝑖𝑡 be the total population of the i LGA, then the fraction of population (of i LGA) in j
th

th

th

distance ring (denoted by 𝐹𝐹𝐹𝑖,𝑗 ) is given by:
𝐹𝐹𝐹𝑖,𝑗 =

𝑝

𝑃𝑖,𝑗

(2)

𝑃𝑖𝑡

under the condition ∑ 𝐹𝐹𝐹𝑖,𝑗 =1 for each LGA.

D. Radiotherapy based treatment demand estimation
The predicted cancer cases and distance-based LGA ratios (𝐹𝐹𝐹𝑖,𝑗 ) were used together with

the radiotherapy rates to estimate the future demand for RT services. The RT rates were
chosen based on the distance bands provided in Gabriel et al. (2012). They calculated the
actual radiotherapy treatment rates for cancer patients in NSW & ACT (2004-06) from
patient treatment records to estimate the effects of geographic variations on the RT rates. The
road distance between patient residence and the nearest RT centre was estimated to compute
the rates of radiotherapy for patients living <50Km, 50 -99Km, 100-149 Km, 150-199 Km,
200-249 Km, 250-299 Km, 300-349 Km, 350-399, and 400+ Km. The dataset used for this
8

study was from 2004-2006. Since this dataset is nearly 10 years old, we have added another
data source, i.e., local health district cancer treatment data containing radiotherapy data for
years 2006 -2012. This local health district is out of the eight in NSW. Using both of these
datasets we have estimated the average radiotherapy rates for cancer patients based on their
driving distances to the nearest RT facilities. The combined average rates for RT are
presented in Table 1.
Table 1: Radiotherapy rates based on driving distances
Distance
Average rates
<50KM
0.339825
50-100KM
0.30606
100-150KM
0.268176
150-200KM
0.24006
201-250KM
0.2276
251-300KM
0.214825
301-350KM
0.216063
351-400KM
0.18525
>400KM
0.161785

Delaney et al. (2005) have summarised the overall optimal radiotherapy utilization rate for
individual cancers such as skin, breast, lung, gastrointestinal, genitourinary and others.
Evidence for radiotherapy based treatments such as systematic review of relevant randomised
studies, randomised/controlled trials, and case series, were used in modelling decision trees
for determining optimal radiotherapy rates. For more information about these rates and
methodology see Delaney (2007). The optimal RT rates varied from 0% in case of liver
cancer patients and 92% for patient with central nervous system tumors. The optimal
radiotherapy utilisation rate was estimated to be 52.3% of all the notifiable cancer in
Australia. The SSDB (2012) report indicates that an additional 23% of the cancer patients
receive at least 2 course of RT (retreatment). Some retreatments are for second cancer and
other for metastatic events. We have used the estimated rate of 52.3% for determining the
optimal RT demand for the future year.
2.3 Evaluation of new radiotherapy centres based on efficiency, service availability and
equity
We have used the proposed modelling work to estimate the change in patient access with the
opening of new RT centre. We have employed three measures to quantitatively
assess/evaluate the locations of new RT centres – general efficiency, service availability and

9

equity. These measures have been used previously to evaluate locations of healthcare
facilities (Batta et al. 2014, Burkey et al. 2012).
A. General efficiency: for general efficiency, we have considered the average distance
between any potential cancer patient and his closest RT facility. In literature, various
researchers have used such measures for evaluating facility location problems in
healthcare. Batta et al. (2014) have used dispersion and population criteria as the
proxies for measures of general efficiency. They focussed on minimising the cost of
providing the service. We are using this measure as a proxy for general efficiency for
RT service provision.
B. Service availability: The proxy for service availability is defined to be the population
coverage for RT treatments. Specifically, the coverage can be measured as the
proportion of the potential cancer patients that is located within a pre-specified
distance from their closest RT facility. This measure of coverage was first defined by
Toregas et al. (1971). According to this measure, a cancer patient is considered
covered if he is living no farther than 50KMs from the closest facility. The union of
coverage areas for each RT centre is then represents service availability. We are
considering 50 KM as the coverage driving distance because previous research studies
(Gabriel et al. 2012) and our analysis of cancer treatment records indicated that
patients living less than 50 Kms from the closest RT facility were receiving highest
rates of radiotherapy based treatments. Radiotherapy is considered a necessary
component of treatment in 52% of all newly diagnosed cancers (Delaney et al. 2005).
Radiotherapy is considered to be most cost effective than surgery and chemotherapy,
when all costs across the life cycle is considered (Ploquin and Dunscombe 2008).
C. Equity: the equity measure helps to quantify aspects related to fairness, justice of the
service provision, and neediness. Burkey et al. (2012) have used a measure known as
Gini index, which is based on Lorenz curve in economics. These curves are used as a
graphical illustration of inequality for any quantitative study where inequality is
measured. Gini index is a scalar measure based on Lorenz curve to quantify inequality
(Gini 1921). Gini index is always between 0 (indicating total equality) and 1
(indicating total inequality). We have used this measure for determining the equality
for potential cancer patients to access RT based treatment.
All of these measures are used to evaluate the alternative locations of new RT centres. All the
methods in this section are coded in R, which is an open source software environment for
10

statistical computing and graphics using open source R libraries such as maptools, ggplot2,
plyr, ineq, rgeos, rgdal, sp, RColorBrewer for this approach development and data analysis.
Interested parties can access the software tools developed in this study freely by contacting
authors.

3. Results and Discussion
This study estimates a spatially explicit demand and accessibility for radiotherapy services in
the NSW state of Australia using methods described above. The choice of the NSW was
justified by the accurate data currently available for NSW and a well-defined geographical
area that is known to mirror average demographic distributions in Australia. Figure 2
illustrates population grid (1Km2) distributed in the whole of NSW state and existing
locations of RT centres in NSW.
Non-linear regression for each age-sex group were conducted on the past cancer incidence
data from AIHW. In both males and females, a statistically significant time trend was found
for the following groups (α<.05): ‘40-44 yrs’, ‘45-49 yrs’, ‘50-54 yrs’, ‘55-59 yrs’, ‘60-64
yrs’, ‘65-69 yrs’, ‘70-74 yrs’, ‘75-79 yrs’, ‘80-84 yrs’, and ‘85+ yrs’. Figure 3 illustrates the
results from non-linear regression analysis (all age groups combined) of cancer incidences
projected in future and its comparison with the past incidence rates. In Figure 3, the overall
rates for cancer incidence in females are not increasing compared to the incidences in males.
The dotted lines in Figure 3 represent the results of the model and the solid lines represent the
actual rates observed. The results of the ASR prediction model for future years were then
applied to the ABS population projections.
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Figure 2: Distribution of population grid (1Km2) and radiotherapy centres in the NSW state

Figure 3: Predicted (points) and observed (solid line) incidence rates (per 100,000) for all
cancers in males and females in Australia
The NSW population data provided by the ABS was used in this study. Figure 4 illustrates
the growth in overall population of NSW from 2011 to 2026. It is evident that the population
will grow significantly in future. However, the growth in population in different age groups
and sex varies across NSW.
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Figure 4: Projected population between 2011 and 2026 based on ABS population projections
Figure 5 illustrates the growth of population in different age-sex group in year 2011 and
2026. In year 2026, number of individuals in age groups with a higher cancer incidence (i.e.,
above 50 years) will be larger than 2011 for both females and males (see Figure 5). There
will be more aged people living in year 2026 in NSW, and because of cancer incidence in the
aged population sub-groups, more cancer cases.

Figure 5: Age structure of NSW population in years 2011 and 2026
Figures 6a and 6b illustrate the cancer incidences (cancer cases per 100,000 individuals) for
year 2011 (Figure 6a) and future year 2026 (Figure 6b). The cancer incidences in all the local
government area (LGA) of NSW (total of 154) are based on the age-sex specific rates
obtained based on non-linear regression modelling (as discussed in Section 2.2.A) and future
13

population estimates data (see Figure 5). In year 2011, the average cancer incidence at LGA
level is approximately 612 per 100,000 individuals. However, it increases to 805 (approx.)
per 100,000 individuals for future year 2026. Based on the spatial distribution of cancer
incidences in year 2011 and 2026, which suggests more cancer cases in the coastal, mideastern and southern LGAs of NSW, planning of radiotherapy services for these areas are
important.

(a)

(b)
Figure 6: Overall cancer incidences in year 2011 (a) and 2026 (b) in NSW state of Australia
Figure 7 depicts driving distance polygons or the accessible regions considering all
radiotherapy centres as trip origins. We have included existing radiotherapy centres in the
NSW and also the nearby centres from the two bordering states- Victoria and Queensland.
This was done to account for patient leakage in to those centres from NSW. As described in
14

Section 2.2.C, for each LGA the fraction of population living in each distance band is
estimated. Table 2 shows these calculated fractions for two LGAs as an example.

Figure 7: Constant driving distance polygons from radiotherapy centres

Table 2. Estimated fractions of population living in constant driving distance bands from
radiotherapy centres
LGA
Hawkesbury
Hawkesbury
Hawkesbury
Wingecarribee
Wingecarribee

Distance band
< 50
50 - 99
100 - 149
< 50
50 - 99

Fraction of
population (𝐹𝐹𝐴𝑖,𝑗 )

0.88
0.11
0.01
0.15
0.85

The distance-based LGA ratios (𝐹𝐹𝐹𝑖,𝑗 ) in the NSW (illustrated in Table 2) were used

together with the cancer cases for respective LGA (illustrated in Figure 6) to estimate the
total number of cancer patients residing in each distance band. The cancer cases residing in
each distance band can be used for planning and locating new radiotherapy centres.
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Table 3 provides the comparison/validation of the proposed model with the actual cancer
cases data from Cancer Institute NSW for a local health district (CI-NSW, 2014). The most
up to date data available for comparison from Cancer Institute NSW is from 2004-2008 and
therefore it is used in this study for comparison purposes. Average actual cancer counts per
year shows that the proposed result for year 2011 matches closely. It can be seen that the
predicted results are on slightly high compared to actual numbers. This is due to the fact that
the predictions were made for the year 2011-2015, and it is compared against actual cancer
counts from year 2004-2008.
Table 3. Comparison between actual cancer incidence dataset and predicted results
Local Government
Area
Kiama
Shellharbour
Shoalhaven
Wollongong
NSW

Actual Cancer Count
(2004- 2008)
627
1,475
3,481
5,223
177,519

Average Actual
Cancer
Count/year
125
295
696
1,045
33,504

Predicted Count
(2011)

Predicted Count
(2011-2015)

150
369
765
1,224
41,229

815
1,987
3,987
6,482
218,700

The proposed approach was then applied to estimate change in access of cancer patients with
the opening of new radiotherapy centre in Shoalhaven LGA (see Figure 3). We have run the
travel distance modelling method for the scenarios before and after opening of new RT
centre. The change in cancer patient’s access for before and after opening of RT centre is
presented in Figure 8. It can be seen that there are more than 600 cancer cases residing in the
50 km road distance from the nearest RT centre when the new RT centre is operational. The
number of RT cases residing within 50km of nearest RT centre in the Illawarra and
Shoalhaven local health district before and after is 1120 and 1511. Interestingly, within 6
months of opening the Shoalhaven RT service is already managing 500 new RT cases per
month (A.Miller, personal communication). Due to the opening of new centre, there are less
cancer cases living in distance bands (in km) 50-99, 100-149, 150-199, 200-249, therefore the
difference between the numbers of cancer cases is negative. For larger distance bands (250299, 300-349, 350-399, 400+), the number of cancer cases are constant for before and after
RT centre placement.
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Figure 8: Change in cancer cases access before and after opening of new RT centre in
Shoalhaven
To further illustrate the applicability of proposed approach, we have compared different
scenarios of placement of RT units in NSW. For this, we considered two potential locations
in NSW to place new RT facility – (i) Dubbo; and (ii) Moruya (see Fig. 9). These scenarios
are then compared in terms of general efficiency; service accessibility and RT service
equality (see Section 2.3). The results of the comparison are presented in Table 4.

Figure 9: Potential locations for new RT centre used for scenario analysis
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Table 4 shows that opening a new RT centre at Dubbo or Moruya offers advantages in terms
of accessibility to cancer patients. Scenario – Dubbo presents better opportunity for general
efficiency improvement (i.e. 5.19% more than the baseline), service availability improvement
(0.71% more); and, service equality increases by 1.51% compared to baseline. However, for
the case where new RT facility has to be opened in Moruya, the general efficiency and
service availability increases by 3.88% and 0.59%, but the distance based equality for RT
services decreases by 0.47%. This implies that opening new RT centre in Dubbo offers better
accessibility measures compared to Moruya. It should be noted that the Gini index
(inequality) measure presented in Table 4 should be minimised.
Table 4: Comparison of scenarios based on general efficiency, service accessibility and
service equality
General Efficiency
Scenario - Dubbo
Scenario - Moruya
Baseline

27.88 (5.19% more)
28.27 (3.88% more)
29.41

Service availability
0.865 (0.71% more)
0.864 (0.59% more)
0.859

Gini Index
(Inequality)
0.408 (1.51% more)
0.416 (0.47% less)
0.414

Table 5 illustrates the demand for the RT services based on the radiotherapy rates estimated
in Section 2.2.D. RT demand at the current service level is calculated by applying RT rates
by road distance (estimated in Table 1) to the number of cancer patients living in each
distance bands (see Section 2.2.B and 2.2.C). However, the optimal RT demand is estimated
by using cancer incidence number and optimal RT utilisation rates (52.3%, see Section
2.2.D).
Table 5: RT demand from year 2011 to 2026
Year
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023

RT Demand at current
service level
13506
13905
14319
14736
15180
15629
16088
16536
16968
17395
17810
18255
18708
18

Optimal RT Demand
based on evidence
17614
18144
18680
19230
19796
20370
20956
21560
22149
22749
23378
24015
24652

2024
2025
2026

19156
19612
20070

25285
25917
26545

It can be concluded from Table 5 that supply of RT services significantly lags behind the
evidence-based optimal demand and new RT centres should be established to deal with such
shortfall. This trend of shortfall will continue in future at the current service levels. The
proposed approach offers an innovative way to assess/evaluate the alternative locations of
new RT services based on – general efficiency, service availability, and equality.

4. Conclusion
The treatment of cancer, which touches a large proportion of the community, represents a
significant health and economic burden in Australia. Nearly one in two men and one in three
women have a lifetime risk of being diagnosed with cancer in NSW. Radiotherapy (RT)
based cancer treatments are often integral to achieving permanent or long-term remission.
There will be large demand for RT services for cancer patients in NSW in next ten years.
However, decision on new linear accelerator (LINAC) units take time, resulting in local
congestion of services or unreasonable travel time for patients, with some individuals opting
out of RT treatment reducing demand but not the need. Thus, there is pressing need to
rationally justify the placement of new radiotherapy centres to effectively meet the future RT
need of future cancer patients. This study makes a unique contribution to the policy debate on
placement of RT treatment centres through the establishment of an integrated modelling
approach. This study marks an attempt at informing the government about the best placement
locations for RT centres to maximise the RT service capacity to meet future cancer patient
demand.
The demonstrated generic approach includes cancer incidence predictive modelling to
estimate the cancer cases residing within different travel distance bands from the RT centres,
and is easily applied to the NSW circumstance. The methods described in this research study
can be applied in other jurisdictions with availability of the necessary data.
We are aware of limitations in our current approach which are being addressed with more
research. We have assumed that the OSM road network data is complete. As the OSM data
becomes more complete in time, we only need to reimport that dataset to update the analysis.
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In estimating future cancer cases, we assume that the residential locations remain the same,
but including research on dynamic land use modelling is expected to better account for
residential area growth. The cancer incidence modelling assumes the same incidence across
different local government areas (LGAs) and that the past trends will continue in future.
Lastly, the model can be refined to include detailed information about the individual cancer
incidences, radiotherapy demand, and accessibility profiles rather than using all inclusive
assessments. In current study, authors are dealing with all types of cancer and their
aggregated rates; therefore, survival analysis is not conducted for different types of cancer
cases and their stages. We hope this type of analysis can be conducted in future based on our
work.
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